Mitsui & Co. Global Investment mitsui-global.com/en

Mitsui & Co. Global Investment (MGI), formerly MVC Corporation, is a subsidiary of Mitsui & Co., Ltd., which invests in opportunities that have potential for growth. While they are headquartered in Tokyo, MGI also has offices in Silicon Valley, Beijing, Mumbai. Its investments reach beyond these geographical barriers, allows MGI to build a diversified global portfolio. MGI's investments are completely independent from its parent company's financial investments and do not have to be strategically...Show all

Mitsui & Co. Global Investment (MGI), formerly MVC Corporation, is a subsidiary of Mitsui & Co., Ltd., which invests in opportunities that have potential for growth. While they are headquartered in Tokyo, MGI also has offices in Silicon Valley, Beiji...Show all

See All Exits Recent Exits

Phone: +81-3-3285-3124

Fax:

Nikkei Bldg, 1-3-7, Otemachi
Chiyoda-ku
 Tokyo, 100-0004
 Japan

Mitsui & Co. Global Investment - Investments & Acquisitions

Show Real Data
See all Recent Investments
Date Company Round Amount Co-investors
2017-05-30CounterTackSeries D - II$20MAlcatel-Lucent Ventures, EDBI, Fairhaven Capital, Goldman Sachs, ManTech, next47, Razors Edge Ventures, SAP National Security Services, SingTel Innov8, and Ten Eleven Ventures
2017-05-22Symic BiomedicalSeries B$30MAlly Bridge Group, Den Danske Forskningsfond, Heda Ventures, InCube Ventures, Lilly Ventures, Mission Bay Capital, Purdue Foundry Investment Fund, and QB3 Garage
2017-03-22AutotalksSeries D$30MAmiti Ventures, Delek Motors, Fraser McCombs Capital, Gemini Israel Ventures, Liberty Israel Venture Fund, Magma Venture Partners, Samsung Ventures, and Vintage Investment Partners
2016-11-01CounterTackSeries D$10MAlcatel-Lucent Ventures, EDBI, Fairhaven Capital, Goldman Sachs, ManTech, next47, Razors Edge Ventures, and Ten Eleven Ventures
2016-10-28Promethera BiosciencesSeries C - II$10.1MBoehringer Ingelheim Venture Fund, Cell Innovation Partners, Fund+, LifeLiver, Mitsubishi UFJ Capital, SMS Investments, Société Régionale d'Investissement de Wallonie, and Vesalius BioCapital
See all 5 investments